Monitoring Acute Changes in Pancreatic Tumor Perfusion with Contrast-Enhanced Ultrasound and Photoacoustic Imaging Following Targeted Hyaluronic Acid Treatment

Simple item page
dc.contributor.advisorHoyt, Kenneth
dc.creatorJaved, Kulsoom
dc.date.accessioned2020-09-03T16:53:45Z
dc.date.available2020-09-03T16:53:45Z
dc.date.created2020-05
dc.date.issued2020-05
dc.date.submittedMay 2020
dc.date.updated2020-09-03T16:53:45Z
dc.description.abstractPancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer related deaths. Early diagnosis is crucial for treating PDAC but is unlikely due to the asymptomatic nature of the tumor in early stages. PDAC is usually diagnosed in late stages when it cannot be resected and is not responsive to chemotherapy (chemoresistance). The chemoresistance and late symptoms are mostly due to the presence of hyaluronan (HA, glycosaminoglycan) in the extracellular matrix (ECM). HA is a marker of tumor aggression and is hydrophilic. It retains water molecules and forms a gel-fluid phase which increases the tumor interstitial pressure, collapses the tumor microvasculature, and causes chemoresistance. HA can be degraded by an enzyme, pegylated pancreatic hyaluronidase (PEGPH20; targeted HA treatment), into its subunits. The aim of this study was to monitor the acute changes in tumor perfusion with contrast enhanced ultrasound and photoacoustic imaging following HA removal by PEGPH20. Athymic nude mice (N=18) were implanted subcutaneously in the peri-tibial region of the right leg with 2 million pancreatic cancer cells. Contrast enhanced ultrasound (CEUS) and photoacoustic (PA) imaging studies were conducted at baseline (0 h) and at 6 h. A single dose of PEGPH20 (treatment) or saline (control) was injected at baseline. After the targeted removal of HA by PEGPH20, the tumor microvasculature expanded and an increase in tumor perfusion parameters; peak enhancement (PE) and wash-in rate (WiR) measured by CEUS, and total hemoglobin signal (HbT) and oxygen saturation (sO2) measured by PA was seen. These changes in CEUS and PA measures were confirmed by histological analysis of the excised tumor tissue. In conclusion, we saw a 50% increase in perfusion parameters at 6 h post treatment as compared to the control group. These acute changes in pancreatic tumor tissue can be monitored noninvasively by CEUS and PA imaging within 6 h of HA removal by PEGPH20.
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/10735.1/8848
dc.language.isoen
dc.rights©2020 Kulsoom Javed. All rights reserved.
dc.subjectContrast-enhanced ultrasound
dc.subjectDiagnostic imaging
dc.subjectPancreas -- Cancer
dc.subjectPancreatic duct
dc.titleMonitoring Acute Changes in Pancreatic Tumor Perfusion with Contrast-Enhanced Ultrasound and Photoacoustic Imaging Following Targeted Hyaluronic Acid Treatment
dc.typeThesis
dc.type.materialtext
thesis.degree.departmentBiomedical Engineering
thesis.degree.grantorThe University of Texas at Dallas
thesis.degree.levelMasters
thesis.degree.nameMS

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
ETD-5608-006T-261894.25.pdf
Size:
2.89 MB
Format:
Adobe Portable Document Format
Description:
Thesis
Download

License bundle

Now showing 1 - 2 of 2
No Thumbnail Available
Name:
LICENSE.txt
Size:
1.84 KB
Format:
Plain Text
Description:
Download
No Thumbnail Available
Name:
PROQUEST_LICENSE.txt
Size:
5.84 KB
Format:
Plain Text
Description:
Download

Collections

UTD Theses and Dissertations